Methods of treatment using anti-mif antibodies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 39/00 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2717071

Disclosed herein, in certain embodiments, is a method for treating an inflammatory disorder. In some embodi-ments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF--activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof.

L'invention concerne, dans certains modes de réalisation, un procédé permettant de traiter un trouble inflammatoire. Dans un certain nombre de modes de réalisation, le procédé consiste à administrer un agent actif qui inhibe (i) la liaison de MIF à CXCR2 et CXCR4 et/ou (ii) l'activation de MIF de CXCR2 et CXCR4; (iii) l'aptitude de MIF à former un homomultimère; ou une combinaison de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treatment using anti-mif antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treatment using anti-mif antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using anti-mif antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1684000

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.